EP3174869
COMBINATION THERAPY OF A MET INHIBITOR AND AN EGFR INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.7.2015EP published:
19.8.2020EP application number:
15747562.5
EPO information:
European Patent Register
Max expiry date:
28.7.2035
Title:
COMBINATION THERAPY OF A MET INHIBITOR AND AN EGFR INHIBITOR
Timeline
Today
29.7.2015EP application
19.8.2020EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
HAO, HuaixiangAddress:
Cambridge, Massachusetts 02139, US
Name:
HUANG, XizhongAddress:
Cambridge, Massachusetts 02139, US
Name:
TAM, AngelaAddress:
Cambridge, Massachusetts 02139, US
Name:
KASIBHATLA, ShailajaAddress:
San Diego, California 92121, US
Priority
Number:
201462031583 PDate:
31.7.2014Country:
US
Classification
Categories:
C07D 401/14, A61K 31/53, A61K 31/55, C07D 487/04, A61P 35/00